POINT Biopharma

SPLASH

NCT04647526

JCP097

Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment (SPLASH)

Status:

Recruiting

26459-200.png

III

Phase

Line of Therapy.png

3rd

Line of Therapy

Disease Stage.png

Advanced / Metastatic

Disease Stage

Target.png

Biomarker(s)

Investigational

Product

[Lu-177]-PNT2002

Treatment Arms

o Experimental: [Lu-177]-PNT2002 (Arm A)

o Active Comparator:
Control Arm (Arm B)